Good Work Environment - Manager Pyxis Oncology Employee Review

Thank you very much for your review. We appreciate your feedback regarding our positive work environment and the team of PYXS employees! We are sorry that your experience wasn't as positive as we would have hoped. Our team remains laser-focused on the clinical development of our lead therapeutic candidate, micvotabart pelidotin (MICVO), a first-in-concept antibody-drug conjugate (ADC), to help improve the lives of patients with cancer. If you have specific concerns or ideas, you’d be open to sharing in more detail, we’d welcome the opportunity to learn from your experience.